Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Study of MG-ZG122 Humanized Monoclonal Antibody in Asthma SubjectsHypersensitivity, Immediate, Respiratory Hypersensitivity, asthma, bronchial disorder, immune system disorder, lung disorder, obstructive lung disease, respiratory system disorderActive, not recruitingPhase 22025-07-08NCT07054034

1 results · Page 1 of 1

Swipe the table sideways for more columns.

OrganizationsLinked trials
Shanghai Mabgeek Biotech.Co.Ltd9

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
China-Japan Friendship Hospital, Beijing, ChinaBeijingChina1